Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation
Dong Jin Shin, Alexander Y Trick, Yu-Hsiang Hsieh, David L Thomas, Tza-Huei Wang, Dong Jin Shin, Alexander Y Trick, Yu-Hsiang Hsieh, David L Thomas, Tza-Huei Wang
Abstract
Gold standard quantitative nucleic acid tests for diagnosis of viral diseases are currently limited to implementation in laboratories outside of the clinic. An instrument for conducting nucleic acid testing at the point-of-care (POC) that is easily operable by the clinician would reduce the required number of visits to the clinic and improve patient retention for proper treatment. Here we present a droplet magnetofluidic (DM) platform, which leverages functionalized magnetic particles to miniaturize and automate laboratory assays for use in the clinic at the POC. Our novel thermoformed disposable cartridge coupled to a portable multiaxial magnetofluidic instrument enables real-time PCR assays for quantitative and sensitive detection of nucleic acids from crude biosamples. Instead of laborious benchtop sample purification techniques followed by elution and spiking into PCR buffer, the user simply injects the biosample of interest into a cartridge with magnetic particles and loads the cartridge into the instrument. We demonstrate the utility of our platform with hepatitis C virus (HCV) RNA viral load quantitation from blood serum in approximately 1 hour. Clinical serum samples (n = 18) were directly processed on cartridges with no false positives and a limit of detection of 45 IU per 10 µl sample injection.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
- Edlin BR, Eckhardt BJ, Shu MA, Holmberg SD, Swan T. Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology. 2015;62:1353–1363. doi: 10.1002/hep.27978.
- IOM (Institute of Medicine). Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C, 10.17226/12793 (The National Academies Press, 2010).
- Hagan H, et al. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep. 2006;121:710–719. doi: 10.1177/003335490612100611.
- Rein DB, et al. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann. Intern. Med. 2012;156:263–270. doi: 10.7326/0003-4819-156-4-201202210-00378.
- Linas, B. P. et al. The hepatitis C cascade of care: Identifying priorities to improve clinical outcomes. Plos One9 (2014).
- Johannessen A. Where we are with point-of-care testing. Journal of Viral Hepatitis. 2015;22:362–365. doi: 10.1111/jvh.12385.
- Unger MA, Chou HP, Thorsen T, Scherer A, Quake SR. Monolithic microfabricated valves and pumps by multilayer soft lithography. Science (80-.) 2000;288:113–116. doi: 10.1126/science.288.5463.113.
- Jiang X, Ng JMK, Stroock AD, Dertinger SKW, Whitesides GM. A miniaturized, parallel, serially diluted immunoassay for analyzing multiple antigens. J. Am. Chem. Soc. 2003;125:5294–5295. doi: 10.1021/ja034566+.
- Zhang Y, et al. A surface topography assisted droplet manipulation platform for biomarker detection and pathogen identification. Lab Chip. 2011;11:398–406. doi: 10.1039/C0LC00296H.
- Shin DJ, Wang TH. Magnetic Droplet Manipulation Platforms for Nucleic Acid Detection at the Point of Care. Ann. Biomed. Eng. 2014;42:2289–2302. doi: 10.1007/s10439-014-1060-2.
- Zhang Y, Nguyen N-T. Magnetic digital microfluidics – a review. Lab Chip. 2017;17:994–1008. doi: 10.1039/C7LC00025A.
- Berry SM, Alarid ET, Beebe DJ. One-step purification of nucleic acid for gene expression analysis via Immiscible Filtration Assisted by Surface Tension (IFAST) Lab Chip. 2011;11:1747. doi: 10.1039/c1lc00004g.
- Chiou CH, Jin Shin D, Zhang Y, Wang TH. Topography-assisted electromagnetic platform for blood-to-PCR in a droplet. Biosens. Bioelectron. 2013;50:91–99. doi: 10.1016/j.bios.2013.06.011.
- Lehmann U, Vandevyver C, Parashar VK, Gijs MAM. Droplet-based DNA purification in a magnetic lab-on-a-chip. Angew. Chemie - Int. Ed. 2006;45:3062–3067. doi: 10.1002/anie.200503624.
- Zhang Y, Wang TH. Full-range magnetic manipulation of droplets via surface energy traps enables complex bioassays. Adv. Mater. 2013;25:2903–2908. doi: 10.1002/adma.201300383.
- Pipper J, et al. Catching bird flu in a droplet. Nat. Med. 2007;13:1259–1263. doi: 10.1038/nm1634.
- Shin DJ, et al. Mobile nucleic acid amplification testing (mobiNAAT) for Chlamydia trachomatis screening in hospital emergency department settings. Sci. Rep. 2017;7:4495. doi: 10.1038/s41598-017-04781-8.
- Scott JD, Gretch DR. Molecular Diagnostics of Hepatitis C Virus Infection. JAMA. 2007;297:724. doi: 10.1001/jama.297.7.724.
- Pawlotsky J-M, et al. Standardization of Hepatitis C Virus RNA Quantification. Hepatology. 2000;32:654–659. doi: 10.1053/jhep.2000.16603.
- Gourlain K, et al. Dynamic Range of Hepatitis C Virus RNA Quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 Assay. J. Clin. Microbiol. 2005;43:1669–1673. doi: 10.1128/JCM.43.4.1669-1673.2005.
- Al-Soud WA, Rådström P. Purification and characterization of PCR-inhibitory components in blood cells. J. Clin. Microbiol. 2001;39:485–93. doi: 10.1128/JCM.39.2.485-493.2001.
- Kodzius R, et al. Inhibitory effect of common microfluidic materials on PCR outcome. Sensors Actuators B Chem. 2012;161:349–358. doi: 10.1016/j.snb.2011.10.044.
- Tone K, Fujisaki R, Yamazaki T, Makimura K. Enhancing melting curve analysis for the discrimination of loop-mediated isothermal amplification products from four pathogenic molds: Use of inorganic pyrophosphatase and its effect in reducing the variance in melting temperature values. J. Microbiol. Methods. 2017;132:41–45. doi: 10.1016/j.mimet.2016.10.020.
- Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology. 2009;49:1335–1374. doi: 10.1002/hep.22759.
- Galbraith JW, et al. Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department. Hepatology. 2015;61:776–782. doi: 10.1002/hep.27410.
- Falade-Nwulia O, et al. Public health clinic-based hepatitis C testing and linkage to care in baltimore. J. Viral Hepat. 2016;23:366–374. doi: 10.1111/jvh.12507.
- World Health Organization. Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version (2016).
- National Institutes of Health Consensus Development Conference Statement Management of hepatitis C 2002 (June 10–12, 2002) Gastroenterology. 2002;123:2082–2099. doi: 10.1053/gast.2002.1232082.
- Ticehurst JR, Hamzeh FM, Thomas DL. Factors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic Hepatitis. J. Clin. Microbiol. 2007;45:2426–2433. doi: 10.1128/JCM.02448-06.
- Deltenre P, et al. A 2-log drop in viral load at 1 month is the best predictor of sustained response in HCV patients with normal ALT: a kinetic prospective study. J. Viral Hepat. 2009;16:500–505. doi: 10.1111/j.1365-2893.2009.01100.x.
- Buti M, Sánchez-Ruano JJ, Morillas RM, Esteban R. Baseline HCV-RNA levels in genotype 1 chronic hepatitis C patients: The role of different cut-off points. Hepatology. 2016;64:1385–1386. doi: 10.1002/hep.28544.
- Núñez M, et al. Baseline Serum Hepatitis C Virus (HCV) RNA Level and Response at Week 4 Are the Best Predictors of Relapse After Treatment With Pegylated Interferon Plus Ribavirin in HIV/HCV-Coinfected Patients. J. Acquir. Immune Defic. Syndr. 2007;45:439–444. doi: 10.1097/QAI.0b013e318061b5d9.
- Zein NN. Clinical significance of hepatitis C virus genotypes. Clin. Microbiol. Rev. 2000;13:223–35. doi: 10.1128/CMR.13.2.223-235.2000.
- Daw MA, Elasifer HA, Dau AA, Agnan M. The role of hepatitis C virus genotyping in evaluating the efficacy of INF-based therapy used in treating hepatitis C infected patients in Libya. Virol. Discov. 2013;1:3. doi: 10.7243/2052-6202-1-3.
- Liu C, et al. A high-efficiency superhydrophobic plasma separator. Lab Chip. 2016;16:553–560. doi: 10.1039/C5LC01235J.
- Bhamla MS, et al. Hand-powered ultralow-cost paper centrifuge. Nat. Biomed. Eng. 2017;1:9. doi: 10.1038/s41551-016-0009.
- Estes MD, et al. Optimization of multiplexed PCR on an integrated microfluidic forensic platform for rapid DNA analysis. Analyst. 2012;137:5510–9. doi: 10.1039/c2an35768b.
- Kim J, Byun D, Mauk MG, Bau HH. A disposable, self-contained PCR chip. Lab Chip. 2009;9:606–612. doi: 10.1039/B807915C.
- Song J, et al. A Multifunctional Reactor with Dry-Stored Reagents for Enzymatic Amplification of Nucleic Acids. Anal. Chem. 2018;90:1209–1216. doi: 10.1021/acs.analchem.7b03834.
- Stark A, Shin DJ, Pisanic T, Hsieh K, Wang TH. A parallelized microfluidic DNA bisulfite conversion module for streamlined methylation analysis. Biomed. Microdevices. 2016;18:1–7. doi: 10.1007/s10544-015-0029-8.
- Gachon C, Mingam A, Charrier B. Real-time PCR: what relevance to plant studies? J. Exp. Bot. 2004;55:1445–1454. doi: 10.1093/jxb/erh181.
- Hamond C, et al. Urinary PCR as an increasingly useful tool for an accurate diagnosis of leptospirosis in livestock. Vet. Res. Commun. 2014;38:81–85. doi: 10.1007/s11259-013-9582-x.
- Mirmajlessi SM, Destefanis M, Gottsberger RA, Mänd M, Loit E. PCR-based specific techniques used for detecting the most important pathogens on strawberry: a systematic review. Syst. Rev. 2015;4:9. doi: 10.1186/2046-4053-4-9.
- Tichopad A. Standardized determination of real-time PCR efficiency from a single reaction set-up. Nucleic Acids Res. 2003;31:122e–122. doi: 10.1093/nar/gng122.
- Pisanic TR, et al. DREAMing: A simple and ultrasensitive method for assessing intratumor epigenetic heterogeneity directly from liquid biopsies. Nucleic Acids Res. 2015;43:1–15. doi: 10.1093/nar/gkv795.
Source: PubMed